Rubin Jonathan Insider Trades

Insider Trading History

Track insider trading activity for Rubin Jonathan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $58.3k 1,250 shares
Last Trade
Feb 25, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$70.4k 1,250 shares
$56.32
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $654k 14,016 shares
Last Trade
Feb 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.4k 1,250 shares
$56.32
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $622k 13,341 shares
Last Trade
Feb 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$34.2k 675 shares
$50.69
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $627k 13,437 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 3,125 shares
$53.30
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $596k 12,766 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$87.6k 1,643 shares
$53.30
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $157k 3,375 shares
Last Trade
Feb 24, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$167k 3,125 shares
$53.30
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $630k 13,500 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$828k 16,500 shares
$50.20
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $514k 11,015 shares
Last Trade
Sep 25, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.8k 840 shares
$46.21
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Sep 25, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$88.5k 1,875 shares
$47.18
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $553k 11,855 shares
Last Trade
Sep 25, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$88.5k 1,875 shares
$47.18
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $87.5k 1,875 shares
Last Trade
Sep 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.6k 1,875 shares
$46.21
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $503k 10,789 shares
Last Trade
Mar 05, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$48.5k 1,468 shares
$33.05
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $117k 2,500 shares
Last Trade
Feb 23, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$41.3k 1,250 shares
$33.05
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $518k 11,103 shares
Last Trade
Feb 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 1,250 shares
$33.05
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $410k 8,780 shares
Last Trade
Feb 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62k 1,875 shares
$33.05
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62k 1,875 shares
$33.05
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $366k 7,853 shares
Last Trade
Feb 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.6k 927 shares
$33.05
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $933k 20,000 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$670k 20,000 shares
$33.52
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $87.5k 1,875 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 1,875 shares
$39.15
$46.66
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Svp, Chief Medical Officer
Holding Value $308k 6,595 shares
Last Trade
Dec 27, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.2k 1,102 shares
$35.59
$46.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up